BiomX Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $332K0.0% YoYTTM through 31 Dec 2025
Net Income -$36.2MTTM through 31 Dec 2025
Free Cash Flow -$26.5MTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Gross Margin | 0.0% |
| Operating Margin | -12,489.8% |
| Net Margin | -10,903.3% |
Balance Sheet Health
Debt / Equity0.00x
Current Ratio0.87x
Net Debt-$3.6Mnet cash position
Cash & Equivalents$5M
Quality Metrics
FCF Margin-7,978.9%
Earnings-Beat Rate50.0%
Dividend
No dividend
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.